domingo, 31 de julio de 2011

The Pains of Being Pure at Heart - "The Body"



En cuanto al videoclip, como bien señalan los chicos de Pitchfork, parece que se han inspirado en aquella regresión infantil que se marcó el genio Spike Jonze con el videoclip de The Notorius B.I.G. y 112 Sky’s The Limit en 1997. Así, vemos una combinación de imágenes de lo que podría ser el día a día de Kip, Kurt, Peggy y Alex con la de una versión infantil clonada de ellos mismos jugando en la playa. Gran videoclip que consigue transmitirnos buenrollismo infantil y estival a partes iguales. (Ver)

Come on now stop staring at the ceiling
Your last daydream is slowly unreeling
Won’t you come out tonight, like I know you want to
Cuz the city’s alive and even though it haunts you, I want you


To tell me again what the body’s for
Cuz I can’t feel it anymore
I want to hurt like it did before
We shouldn’t sin

Tell me again what the body’s for
Cuz I can’t feel it anymore
I lost mine and I need yours,
It’s only skin, we could swim

You try so hard to keep it together,
And you look so hard in fishnets and leather
But I know who you are, you are just a lost saint
And if we go too far, there’ll be heaven to pay
And what a price…

I can’t feel it anymore, tell me again what the body’s for
I can’t feel it anymore, tell me again it’s only skin, we should swim

sábado, 30 de julio de 2011

Alberto Tejada Noriega, médico, árbitro y nuevo Ministro de Salud en Perú pone los puntos sobre....

Médico de profesión, especialista en urología y sexología, ha sido alcalde del distrito de San Borja entre 2003 y 2010. También se ha desempeñado como árbitro de fútbol.

A partir del 28 de julio, asumirá el cargo de ministro de Salud, el médico Alberto Tejada Noriega, quien ha sido designado por el presidente electo, Ollanta Humala.

Tejada Noriega es médico de profesión, especialista en urología y sexología.

Ha sido alcalde del distrito limeño de San Borja entre 2003 y 2010.

A sus 54 años llegará al Ejecutivo, integrando el Gabinete inaugural del Gobierno entrante, pero lejos de su paso por la política destaca su faceta como árbitro de fútbol.

Es hijo del también ex árbitro FIFA, Alberto Tejada Burga. (Ver)


Como árbitro "defiende los puntos"...


Como médico "pone los puntos...claros".



Cómo Ministro de Salud...???

Ver también:

Humor...es lunes: Nueva "Menestra" de salud...

viernes, 29 de julio de 2011

Ratón de biblioteca: ARRUGAS Paco Roca/ Colabora Rosa M. Nieto*


















Libreria Praga / Granada


Ayer tarde con algunas comprillas por hacer en el pueblo (nada de ir a la capital), nos sorprendió la apertura de una librería muy atractiva en el centro del pueblo, atrevido negocio para los tiempos que corren, y mas para un pueblo que no alcanza los 6000 habitantes. Con un diseño muy atractivo invitaba a entrar y volvía a llover, excusa perfecta para estar un buen rato en la librería.
Salí encantada por la apuesta de los dueños, con un libro entre las manos y un nuevo concepto aprendido, Arrugas y "narrativa gráfica" .


Paco Roca aborda en Arrugas temas delicados, hasta ahora escasamente tratados en historieta, como son el Alzheimer y la demencia senil. Y lo hace de un modo intimista y sensible, con algunos apuntes de humor pero sin caer en ningún momento en la caricatura. El aire de verosimilitud que se respira en el relato se ha visto propiciado por un cuidadoso trabajo de documentación. Paco Roca comenzó a recopilar anécdotas de los padres y familiares ancianos de sus amigos y visitó residencias de ancianos para saber cómo era la vida en ellas, un material de primera mano que le ha servido para estructurar una consistente ficción.

Arrugas cuenta con precisión la batalla contra la vejez.
Una batalla sin armas y no exenta de lágrimas.

El autor es todo un ídolo en Francia y sus novelas gráficas triunfan en media Europa.

Ver animación sobre la historia : ARRUGAS-ANIMACIÓN


Arrugas from vixel on Vimeo.

No dudo en recomendarlo. Imprescindible.

*Colabora:

Rosa María Nieto es enfermera. Además estudió Antropología Social y Cultural (Univ.Granada). Actualmente trabaja como Supervisora de Servicios en el SAS (Servicio Andaluz de Salud). Es editora del blog Enfermera 2.o: la mirada enfermera que dice hacer
"con un toque de humanismo, arte y humor"

Sostiene no Pereira sino Pepe Bravo o...dónde está el "pharmageddon"?


Menos mal que vamos mal...

Sostiene Pepe Bravo (amigo), editor de Las Mentiras de la Industria Farmacéutica, que las noticias sobre la industria hay que buscarlas en la "prensa salmón" porque es el lugar donde aparecen...

De ella tomamos las "verdades" que encabezan esta nota.
La publica Maribel R. Coronel (amiga) en EL ECONOMISTA (México, 24 julio 2011):

"Con todo y sus complejos problemas por el vencimiento de muchas patentes, la lentitud en la salida de nuevas, el boom de los genéricos y un bajo o nulo crecimiento en el mundo desarrollado, la industria de medicamentos alcanzará un valor superior a 1 millón de millones (1 billón) de dólares para el 2015.

Al menos así lo calcula IMS Health -líder mundial en inteligencia de negocios en este sector-, en cuyas cifras se confía para saber el tamaño de los distintos mercados farmacéuticos de todo el mundo."


Aclara sobre las inquietudes catastrofistas del inminente "pharmageddon" anunciado por los voceros de Farmaindustria.

En nuestro insistente investigar complementamos con...

Los suizos no van mal...

Los americanos tampoco...


Ni los ingleses...


Y tampoco los genéricos...

Enfin, como dice Pepe Bravo, "Las mentiras de la industria farmacéutica" ( según la "prensa salmón")

Menos mal que vamos mal...y que iremos mejor (piensan).

Informe QUIRAL: Alzheimer







Palabras más frecuentes contenidas en los titulares de la prensa española de 1997 a 2009 (Informe Quiral) en relación a la enfermedad de Alzheimer









Barcelona 17/06/2011
El 'Informe Quiral 2010' ha dado un giro en su proyecto inicial, para abordar específicamente el tratamiento del Alzheimer en los medios informativos y lo hace desde un enfoque multimedia, al tener en cuenta prensa diaria, radios y televisiones de todo el mundo, además de las redes sociales electrónicas.
Ver y descargar

jueves, 28 de julio de 2011

PFIZER: Las razones (o sinrazones) de la salida de Jeff Kindler



FORTUNE For Jeff Kindler, it was a humiliating moment. The CEO of Pfizer, the world's largest pharmaceutical company, had been summoned to the airport in Fort Myers, Fla., on Saturday, Dec. 4, 2010, for a highly unusual purpose: to plead for his job.

Three stone-faced directors, representing the company's board, sat inside a drab airport conference room as the CEO, trained as a trial lawyer, struggled to argue his most important case. Alerted to this meeting less than 24 hours earlier, Kindler detailed his accomplishments, speaking nonstop for the better part of an hour. He touted his bold reorganizations, praised his administration's sweeping cost reductions, and rhapsodized about his reinvention of Pfizer's crucial research-and-development operations.

But the three board members, Constance Horner, a former deputy secretary at the U.S. Department of Health and Human Services; George Lorch, an ex-CEO of Armstrong World Holdings; and Bill Gray, a former Philadelphia congressman, weren't there to debate the direction of the company. The board had spent a frantic week in an urgent investigation: A revolt had erupted against Kindler among a handful of senior managers, and the directors were trying to figure out what was going on. One possibility: an internal power grab. Another: a CEO who was unraveling.


Más


This article is from the August 15, 2011 issue of Fortune.

Ver también:

Sobrevivir sin LIPITOR o..."escoba nueva bien barre"

Sentimientos "enfrentados" ante la Visita Médica...

Mixed feelings on drug reps

Personally, I have mixed feelings about my profession's relationship with pharmaceutical companies. I must admit something gnawed at me during my stay at the Ritz 10 years ago. The "consultants' meeting" turned out to be a group of 25 doctors who were led through a slide presentation on the benefits of the drug being promoted. I realized that I was not in the company of "thought leaders" at all, but rather in a group of ordinary doctors who, like me, wanted a fun -- and free -- weekend in Washington.


I tried to convince myself that the trip and other perks I'd gotten before from drug companies, such as free tickets to Tigers' basketball games, did not influence my prescribing practices. Such rationalization is probably common. A 2000 study in the Journal of the American Medical Association found that the more gifts doctors received, the less likely they were to think that their prescribing behavior was being influenced.

.../...

But for me, something changed five years ago. One drug representative, a tall fellow with blond hair who carried an open laptop, politely but pointedly asked why I wasn't prescribing his company's HIV medicine. He was hinting that he knew what prescriptions I wrote. (I was unaware at the time that drug reps can access doctors' weekly prescribing patterns through a purchasable database.)

For a few seconds, I felt a little guilty about not ordering his product. But guilt was quickly replaced by a feeling I was being manipulated -- and in a way, violated. I asked him to leave my office and not come back. That afternoon I told my secretary to cancel all my appointments with drug reps and not to schedule any more.

My decision came with a price. I no longer have access to the free sample medications that I once gave to my low-income patients. Also, I am not updated regularly on new medications, as I had been through talks sponsored by the drug companies. A year ago, when a pulmonologist asked me about a new anti-fungal medication, I felt embarrassed that I knew little about the drug. A drug rep had briefed him in a visit, but not me.

With thousands of journal articles published each year, and with new drugs and new indications for old drugs regularly being approved by the Food and Drug Administration, it's almost impossible for a busy practitioner to keep up on his own. Doctors often rely on drug company reps to filter information -- a valuable service, but one that can pose its own problems.

Take the case of Vioxx, the painkiller made by Merck. In 2001, a study in the New England Journal of Medicine showed that patients on Vioxx were more likely to have a heart attack than those taking a generic pain medicine. According to a 2005 commentary in Slate, Merck's sales reps continued to market Vioxx and doctors continued to prescribe it until the company voluntarily pulled it from the market in 2004.

Ver

Big pharma and patient care

Doctors' interaction with drug reps is slippery slope, Memphis physician says The Commercial Appeal


Nine of top 10 firms in USA/Europe cut back on sales force


KEVIN GROGAN / WORLD NEWS | JULY 08, 2011

Worldwide spending in 2010 on sales force and other marketing channels edged up 1.5% over the previous year to just over $91 billion, but growth is due to activities in China, Japan and Latin America, as firms made major cuts in the west.

That is the conclusion of a report from market researchers at Cegedim Strategic Data which audits pharmaceuticals marketing expenditure in over 30 countries. It notes that spending on meetings and other events saw an increase of just over 5% worldwide to $13 billion and the use of events was up significantly in Japan (+14%), China (+19%) and Latin America (+18%). However, spending was down in the USA by 17% and Europe saw a decline of 7%.

In 2010, global spending on sales force promotion increased 2.2% to $56.1 billion but cuts in US sales force levels were significant - several major companies reduced their numbers of reps by over 10%. European sales force levels saw significant reductions as well, while in China, Latin America, and Japan many of the leading companies "added reps for double-digit growth", the analysis points out.

Global marketing expenditure among the leading ten companies was nearly flat in 2010 but accounted for over 41% of total marketing investment - the same ratio as 2009. Three of the ten leading companies are American while five are European - two Japanese multinationals complete the top 10.

Christopher Wooden, vice president for the CSD global promotion audit, noted that "in emerging markets, the industry has quickly adopted the use of meetings and events as an efficient way to achieve high quality interaction with a maximum number of healthcare professionals". This stategy "augments one-to-one rep detailing as companies face the challenge of rapid growth and training demands".

He went on to say that "there appears to be a broad trend in seeking scale efficiencies in the major western markets as nine of the top 10 companies in the USA and Europe cut back on sales force levels". Among mature markets, Japan was a major exception with increased spending through 2010 despite flat reported sales.

Mr Wooden added that "with patent expiry, limited R&D pipelines and accompanying industry consolidation, sales force and marketing in the mature western markets will likely be streamlined over the next few years. The future is clearly seen in Asia and Latin America".

Ver

Article Nine of top 10 firms in USA/Europe cut back on sales force


Cambio Rx por playstation, dinero o entradas para el Benfica...


Três médicos do Serviço Nacional de Saúde (SNS) foram acusados do crime de corrupção passiva por receberem de um laboratório farmacêutico envelopes com dinheiro, bilhetes para jogos de futebol e até uma playstation e, em troca, receitarem determinados medicamentos.

O caso começou com uma denúncia, feita em 2010, por um delegado de informação médica de um laboratório de Lisboa, tendo o seu testemunho sido essencial para a acusação do Departamento de Investigação e Acção Penal (DIAP) de Coimbra, deduzida a 20 de Maio.

O denunciante, chamado MF, o seu chefe e o próprio laboratório acabaram por não ser acusados de corrupção activa por os factos que a eles diziam respeito já terem prescrito. Isto porque, a pena aplicável àquele crime, à data dos factos imputados a este três arguidos (entre 2005 e 2007), era inferior a seis meses. Hoje, a pena para o mesmo crime vai de um a cinco anos, mas como a lei obriga à aplicação do regime mais favorável aos arguidos, o procedimento criminal foi declarado prescrito.

Estratégia comercial do laboratório

Segundo o depoimento de MF, o laboratório suspeito encarava a entrega de contrapartidas a clínicos que prescrevessem os seus medicamentos como uma mera estratégia comercial. Assim, quanto mais embalagens fossem receitadas, maior seria o valor da contrapartida.

As ‘prendas’ do laboratório consistiam em viagens, fins-de-semana em estâncias turísticas, bilhetes para jogos de futebol e espectáculos, cheques-prenda, consolas ou até mesmo dinheiro ‘vivo’ entregue em envelopes.

JR, médico de clínica geral num centro de saúde do distrito de Viseu, aceitou prescrever doses significativas de diversos genéricos de combate ao reumatismo, diabetes e doenças cardiovasculares, em troca de uma playstation 2 (que se encontra apreendida nos autos), de bilhetes para jogos internacionais do Benfica e das respectivas estadas em Lisboa.

No caso da médica CF, que trabalha noutro centro de saúde, está mesmo em causa a entrega de cinco envelopes que continham 500 a 600 euros em notas em troca da prescrição de cinco genéricos comercializados pelo laboratório de MF. Segundo a acusação, foi a própria médica quem escolheu receber ‘dinheiro vivo’ como contrapartida.

Já a clínica geral CR recebeu, com o mesmo objectivo, dois envelopes que continham entre os 200 e os 500 euros.

Congressos em estâncias balneares

O DIAP de Coimbra investigou igualmente mais quatro médicos denunciados por MR por aceitarem estadas em estâncias balneares, com o pretexto de assistir a congressos científicos ou a acções de formação. Contudo, ao contrário dos médicos acusados, estes arguidos não se encontram a trabalhar no SNS em regime de exclusividade. Logo, subsistiu a dúvida sobre se o laboratório suspeito teria tido a intenção de propor aos clínicos a prescrição na sua actividade pública ou privada – o que motivou o arquivamento dos autos.

Todos os médicos envolvidos neste caso, acusados ou não, já estão a ser investigados disciplinarmente pela Ordem dos Médicos, segundo confirmou ao SOL o bastonário, José Manuel Silva.

Ver